These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A RET C634R mutation in a Thai female with multiple endocrine neoplasia type 2A. Sunthornyothin S; Sinthuwiwat T; Shotelersuk V J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S472-6. PubMed ID: 12930027 [TBL] [Abstract][Full Text] [Related]
6. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881 [TBL] [Abstract][Full Text] [Related]
7. Genetic testing in endocrinology: lessons learned from experience with multiple endocrine neoplasia type 2 (MEN2). Jimenez C; Gagel RF Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S150-7. PubMed ID: 15135800 [TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527 [TBL] [Abstract][Full Text] [Related]
11. Mutations in the RET proto-oncogene in medullary thyroid carcinoma. Höppner W Clin Lab; 2007; 53(5-6):283-4. PubMed ID: 17605402 [No Abstract] [Full Text] [Related]
12. Management of patients with hereditary medullary thyroid carcinoma. Fitze G Eur J Pediatr Surg; 2004 Dec; 14(6):375-83. PubMed ID: 15630638 [TBL] [Abstract][Full Text] [Related]
13. Cost analysis of DNA-based testing in a large Canadian family with multiple endocrine neoplasia type 2. Gilchrist DM; Morrish DW; Bridge PJ; Brown JL Clin Genet; 2004 Oct; 66(4):349-52. PubMed ID: 15355438 [TBL] [Abstract][Full Text] [Related]
14. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal. Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668 [TBL] [Abstract][Full Text] [Related]
15. Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients. Lesueur F; Cebrian A; Cranston A; Leyland J; Faid TM; Clements MR; Robledo M; Whittaker J; Ponder BA J Clin Endocrinol Metab; 2005 Jun; 90(6):3454-7. PubMed ID: 15741265 [TBL] [Abstract][Full Text] [Related]
16. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer. Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370 [No Abstract] [Full Text] [Related]
17. [Medullary cancers of the thyroid: genetic aspects]. Orgiazzi J Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251 [No Abstract] [Full Text] [Related]
18. Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. Huang SC; Torres-Cruz J; Pack SD; Koch CA; Vortmeyer AO; Mannan P; Lubensky IA; Gagel RF; Zhuang Z J Clin Endocrinol Metab; 2003 Jan; 88(1):459-63. PubMed ID: 12519890 [TBL] [Abstract][Full Text] [Related]
19. [Multiple endocrine neoplasia 2A type: a genetic study of one family]. Arias Miranda IM; Casal Alvarez F; Castaño L Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101 [No Abstract] [Full Text] [Related]
20. [A familial form of medullary carcinoma of the thyroid gland]. Rotin DL; Brzhezovskiĭ VZh; Pavlovskaia AI; Smirnova EA; Anurova OA Arkh Patol; 2003; 65(3):7-9. PubMed ID: 12879602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]